Stage IIIB Breast Cancer Recruiting Phase Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01824836A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)Supportive Care